Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March

Vertex Pharmaceuticals is letting go of 125 employees in Rhode Island after a clinical disappointment for its Phase 1/2 type 1 diabetes program. The Boston-based drugmaker is consolidating three of its buildings ...